Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR-Cas9 in cancer therapeutics.

Progress in molecular biology and translational science - 1 Jan 2021

Randhawa Shubhchintan

Abstract excerpt

Cancer is a disease mainly caused by an accumulation of mutations in cells. Consequently, correcting those genetic aberrations could be a potential treatment strategy. The traditional route for cancer drug development is tedious, laborious, and time-consuming. Due to target identification, drug formulation, pre-clinical testing, clinical testing, and regulatory hurdles, on average, it takes 10-15 years for a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR-Cas Systems
Share to Gene Editing
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Source

Identifiers

PMID: 34127191
DOI: 10.1016/bs.pmbts.2021.01.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR-Cas9 in cancer therapeutics.PMID 34127191Read ↗

CRISPR-Cas9 as a Potential Cancer Therapy Agent: An UpdateSemantic proximity Read ↗

Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and ChallengesSemantic proximity Read ↗

CRISPR/Cas9 technology in tumor research and drug development application progress and future prospectsSemantic proximity Read ↗

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future ResearchSemantic proximity Read ↗

CRISPR/Cas9 for Cancer Therapy: Hopes and ChallengesSemantic proximity Read ↗

CRISPR/Cas9 application in cancer therapy: a pioneering genome editing toolSemantic proximity Read ↗

CRISPR/Cas9: Role of genome editing in cancer immunotherapySemantic proximity Read ↗

CRISPR/Cas9-Mediated Genome Editing in Cancer TherapySemantic proximity Read ↗

The Potential Revolution of Cancer Treatment with CRISPR TechnologySemantic proximity Read ↗

Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.Semantic proximity Read ↗

CRISPR-Cas9 in basic and translational aspects of cancer therapySemantic proximity Read ↗

CRISPR/Cas9 for cancer treatment: technology, clinical applications and challengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.